Cargando…
Cohort selection for clinical trials using deep learning models
OBJECTIVE: The goal of the 2018 n2c2 shared task on cohort selection for clinical trials (track 1) is to identify which patients meet the selection criteria for clinical trials. Cohort selection is a particularly demanding task to which natural language processing and deep learning can make a valuab...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798560/ https://www.ncbi.nlm.nih.gov/pubmed/31532478 http://dx.doi.org/10.1093/jamia/ocz139 |
Sumario: | OBJECTIVE: The goal of the 2018 n2c2 shared task on cohort selection for clinical trials (track 1) is to identify which patients meet the selection criteria for clinical trials. Cohort selection is a particularly demanding task to which natural language processing and deep learning can make a valuable contribution. Our goal is to evaluate several deep learning architectures to deal with this task. MATERIALS AND METHODS: Cohort selection can be formulated as a multilabeling problem whose goal is to determine which criteria are met for each patient record. We explore several deep learning architectures such as a simple convolutional neural network (CNN), a deep CNN, a recurrent neural network (RNN), and CNN-RNN hybrid architecture. Although our architectures are similar to those proposed in existing deep learning systems for text classification, our research also studies the impact of using a fully connected feedforward layer on the performance of these architectures. RESULTS: The RNN and hybrid models provide the best results, though without statistical significance. The use of the fully connected feedforward layer improves the results for all the architectures, except for the hybrid architecture. CONCLUSIONS: Despite the limited size of the dataset, deep learning methods show promising results in learning useful features for the task of cohort selection. Therefore, they can be used as a previous filter for cohort selection for any clinical trial with a minimum of human intervention, thus reducing the cost and time of clinical trials significantly. |
---|